Brief: Brickell Biotech Reports Q2 2022 Results
Aug 11 (Reuters) - Brickell Biotech Inc BBI.O :
* BRICKELL BIOTECH REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
* BRICKELL BIOTECH INC - EXPECTS ITS CASH AND CASH
EQUIVALENTS AS
OF JUNE 30, 2022, WILL SUPPORT ITS OPERATIONS FOR AT LEAST THE
NEXT 12 MONTHS
* BRICKELL BIOTECH INC - QTRLY LOSS PER SHARE $0.01
Source text for Eikon: ID:nGNX5hdbfb
Further company coverage: BBI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Botanix Pharmaceuticals
See all newsBrief: Botanix Pharmaceuticals Receives Notice Of Allowance For Additional US Patent Covering Sofdra Drug Substance
Brief: Botanix Pharmaceuticals Appoints Paul Seaback As Chief Operating Officer
Brief: Botanix Pharmaceuticals Reaches Term Sheet Agreement With Second API Supplier
Botanix Pharmaceuticals jumps on supply agreement with PPL Pharma Solutions
Brief: Botanix Pharmaceuticals Posts HY Loss Attributable A$33.2 Million